These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ; Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115 [TBL] [Abstract][Full Text] [Related]
45. Relationship between symptom-onset-to-balloon time and long-term mortality in patients with acute myocardial infarction treated with drug-eluting stents. Cho YW; Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DI; Lee SH; Cho YK; Kim DS J Cardiol; 2011 Sep; 58(2):143-50. PubMed ID: 21764561 [TBL] [Abstract][Full Text] [Related]
46. Predictors and outcome of grade 3 ischemia in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Postma S; Heestermans T; Ten Berg JW; van Werkum JW; Suryapranata H; Birnbaum Y; Hamm CW; van 't Hof AW J Electrocardiol; 2011; 44(5):516-22. PubMed ID: 21871998 [TBL] [Abstract][Full Text] [Related]
47. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. Wiviott SD; Morrow DA; Frederick PD; Giugliano RP; Gibson CM; McCabe CH; Cannon CP; Antman EM; Braunwald E J Am Coll Cardiol; 2004 Aug; 44(4):783-9. PubMed ID: 15312859 [TBL] [Abstract][Full Text] [Related]
48. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142 [TBL] [Abstract][Full Text] [Related]
49. Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Damman P; Woudstra P; Kuijt WJ; Kikkert WJ; van de Hoef TP; Grundeken MJ; Harskamp RE; Henriques JP; Piek JJ; Tijssen JG; de Winter RJ J Interv Cardiol; 2013 Feb; 26(1):8-13. PubMed ID: 22971136 [TBL] [Abstract][Full Text] [Related]
50. [Type of treatment and short-term outcome in elderly patients with acute myocardial infarction admitted to hospitals with a primary coronary angioplasty facility. The TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry]. Bardají A; Bueno H; Fernández-Ortiz A; Cequier A; Augé JM; Heras M Rev Esp Cardiol; 2005 Apr; 58(4):351-8. PubMed ID: 15847731 [TBL] [Abstract][Full Text] [Related]
51. [Admission hyperglycemia and mortality of ST segment elevation myocardial infarction]. Greig D; Corbalán R; Castro P; Campos P; Lamich R; Yovaniniz P; Nazzal C Rev Med Chil; 2010 Sep; 138(9):1109-16. PubMed ID: 21249278 [TBL] [Abstract][Full Text] [Related]
52. New risk score for patients with acute chest pain, non-ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score. Sanchis J; Bodí V; Núñez J; Bertomeu-González V; Gómez C; Bosch MJ; Consuegra L; Bosch X; Chorro FJ; Llàcer A J Am Coll Cardiol; 2005 Aug; 46(3):443-9. PubMed ID: 16053956 [TBL] [Abstract][Full Text] [Related]
53. Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. Martinoni A; De Servi S; Boschetti E; Zanini R; Palmerini T; Politi A; Musumeci G; Belli G; De Paolis M; Ettori F; Piccaluga E; Sangiorgi D; Repetto A; D'Urbano M; Castiglioni B; Fabbiocchi F; Onofri M; De Cesare N; Sangiorgi G; Lettieri C; Poletti F; Pirelli S; Klugmann S; Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):526-32. PubMed ID: 21450642 [TBL] [Abstract][Full Text] [Related]
54. Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors. De Luca G; Gibson MC; Hof AW; Cutlip D; Zeymer U; Noc M; Maioli M; Zorman S; Gabriel MH; Secco GG; Emre A; Dudek D; Rakowski T; Gyongyosi M; Huber K; Bellandi F; J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):815-20. PubMed ID: 23519096 [TBL] [Abstract][Full Text] [Related]
55. Renal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Ferrer-Hita JJ; Dominguez-Rodriguez A; Garcia-Gonzalez MJ; Abreu-Gonzalez P Int J Cardiol; 2007 May; 118(2):243-5. PubMed ID: 16997402 [TBL] [Abstract][Full Text] [Related]
56. Association between advanced Killip class at presentation and impaired myocardial perfusion among patients with ST-segment elevation myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors. De Luca G; Gibson CM; Huber K; Zeymer U; Dudek D; Cutlip D; Bellandi F; Noc M; Emre A; Zorman S; Gabriel HM; Maioli M; Rakowski T; Gyöngyösi M; Van't Hof AW; Am Heart J; 2009 Sep; 158(3):416-21. PubMed ID: 19699865 [TBL] [Abstract][Full Text] [Related]
57. Prospective validation of Thrombolysis in Myocardial Infarction and front door Thrombolysis in Myocardial Infarction risk scores in Chinese patients presenting to the ED with chest pain. Graham CA; Chan JW; Chan CP; Cattermole GN; Rainer TH Am J Emerg Med; 2014 Nov; 32(11):1339-44. PubMed ID: 25262326 [TBL] [Abstract][Full Text] [Related]
58. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry). Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127 [TBL] [Abstract][Full Text] [Related]
59. [Prognostic value of circulating catestatin levels for in-hospital heart failure in patients with acute myocardial infarction]. Ji L; Pei ZQ; Ma DF; Zhang J; Su JS; Gao XD; Xue WZ; Chen XP; Wang WS Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Nov; 40(11):914-9. PubMed ID: 23363671 [TBL] [Abstract][Full Text] [Related]
60. Primary percutaneous angioplasty, thrombolysis and conservative treatment in low-risk patients with ST-elevation myocardial infarction: effects on short- and long-term mortality. Grajek S; Araszkiewicz A; Lesiak M; Grygier M; Pyda M; Skorupski W; Mitkowski P; Baszko A Kardiol Pol; 2012; 70(1):1-5. PubMed ID: 22267414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]